Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells.
Mohammed RN, Wehenkel SC, Galkina EV, Yates EK, Preece G, Newman A, Watson HA, Ohme J, Bridgeman JS, Durairaj RRP, Moon OR, Ladell K, Miners KL, Dolton G, Troeberg L, Kashiwagi M, Murphy G, Nagase H, Price DA, Matthews RJ, Knäuper V, Ager A. Mohammed RN, et al. Sci Rep. 2019 Apr 2;9(1):5487. doi: 10.1038/s41598-019-41811-z. Sci Rep. 2019. PMID: 30940840 Free PMC article.
L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy.
Watson HA, Durairaj RRP, Ohme J, Alatsatianos M, Almutairi H, Mohammed RN, Vigar M, Reed SG, Paisey SJ, Marshall C, Gallimore A, Ager A. Watson HA, et al. Among authors: mohammed rn. Front Immunol. 2019 Jun 12;10:1321. doi: 10.3389/fimmu.2019.01321. eCollection 2019. Front Immunol. 2019. PMID: 31249570 Free PMC article.
Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1.
Watson HA, Dolton G, Ohme J, Ladell K, Vigar M, Wehenkel S, Hindley J, Mohammed RN, Miners K, Luckwell RA, Price DA, Matthews RJ, Ager A. Watson HA, et al. Among authors: mohammed rn. Immunol Cell Biol. 2016 Sep;94(8):802-8. doi: 10.1038/icb.2016.45. Epub 2016 Jul 19. Immunol Cell Biol. 2016. PMID: 27430370 Free PMC article.
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F, Tahmasebi S, Rahman HS, Kaigorodov D, Markov A, Yumashev AV, Shomali N, Chartrand MS, Pathak Y, Mohammed RN, Jarahian M, Motavalli R, Motavalli Khiavi F. Marofi F, et al. Among authors: mohammed rn. Stem Cell Res Ther. 2021 Mar 29;12(1):217. doi: 10.1186/s13287-021-02283-z. Stem Cell Res Ther. 2021. PMID: 33781320 Free PMC article. Review.
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
Marofi F, Rahman HS, Thangavelu L, Dorofeev A, Bayas-Morejón F, Shirafkan N, Shomali N, Chartrand MS, Jarahian M, Vahedi G, Mohammed RN, Shahrokh S, Akbari M, Khiavi FM. Marofi F, et al. Among authors: mohammed rn. Stem Cell Res Ther. 2021 Mar 22;12(1):200. doi: 10.1186/s13287-021-02251-7. Stem Cell Res Ther. 2021. PMID: 33752707 Free PMC article. Review.
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F, Tahmasebi S, Rahman HS, Kaigorodov D, Markov A, Yumashev AV, Shomali N, Chartrand MS, Pathak Y, Mohammed RN, Jarahian M, Motavalli R, Khiavi FM. Marofi F, et al. Among authors: mohammed rn. Stem Cell Res Ther. 2021 Aug 6;12(1):443. doi: 10.1186/s13287-021-02523-2. Stem Cell Res Ther. 2021. PMID: 34362452 Free PMC article. No abstract available.
34 results